7498 Results (Page 295 of 300)
Pharmaceuticals Markets Research Reports
Philippines Brugada Syndrome Market Analysis
The Philippines Brugada Syndrome Market was valued at $2.6 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $4.6 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Philippines Brugada Syndrome Market are Ajanta, Pascual Laboratories, Bauch Laboratories, Uni-Pharma Phils, Roche, and Medtronic, among others.
Egypt Blood Disorder Therapeutics Market
Egypt Blood Disorder Therapeutics Market valued at $38 Mn in 2022, projected to reach $75 Mn by 2030 with a 9% CAGR. The market is fuelled due to a push from a mix of certain factors like the increased prevalence of Blood Disorders in the country, supported by increased awareness and acceptance and availability of treatment options due to recent technological advancements. The Egypt Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Roche, Novartis, Pfizer, AstraZeneca, Sanofi, Grifols, Octapharma, Pharco Pharmaceuticals, EVA Pharmaceuticals etc, among various others.
Vietnam Brugada Syndrome Market Analysis
The Vietnam Brugada Syndrome Market was valued at $6 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $12.2 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, geriatric population, and advancements in genetic testing. The prominent players of the Vietnam Brugada Syndrome Market are Nipro Pharma, Sanofi, StellaPharm, Vimedimex, Medtronic, and GSK, among others.
Brazil Blood Disorder Therapeutics Market
Brazil Blood Disorder Therapeutics Market valued at $335 Mn in 2022, projected to reach $643 Mn by 2030 with a 8.5% CAGR. Rising prevalence of blood diseases, advanced therapies, and increased healthcare investment are driving the growth of the Brazil Blood Disorder Therapeutics Market. The Brazil market encompasses various players across different segments, including Pfizer, Sanofi, Novartis, Takeda Pharmaceuticals, CSL Behring, Alexion, Eurofarma, Hypera Pharma, Neo Quimica, Cristalia etc, among various others.
Egypt Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Egypt Clinical Nutrition for Chronic Kidney Diseases Market was valued at $4.40 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, a growing geriatric population, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Egypt Brugada Syndrome Market Analysis
The Egypt Brugada Syndrome Market was valued at $3.4 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $6.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Egypt Brugada Syndrome Market are Raveda Pharma, Eva Pharma, Eipico, Amoun, and Novartis, among others.
France Blood Disorder Therapeutics Market
France Blood Disorder Therapeutics Market valued at $369 Mn in 2022, projected to reach $610 Mn by 2030 with a 6.5% CAGR. The key drivers of the market include greater disposable income among the French population, leading to an increased ability to afford expensive prescription drugs and specialized treatments for blood problems, and changes in the Western lifestyle causing a higher prevalence of the disease in the country. The France Market encompasses various players across different segments, including Takeda, Roche, Sanofi, Novartis, Novo Nordisk, CSL Ltd, Pfizer, LFB Biomedicaments, Walvax Biotech, Janssen-Cilag etc, among various others.
Kenya Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Kenya Clinical Nutrition for Chronic Kidney Diseases Market was valued at $1.10 Mn in 2023 and is predicted to grow at a CAGR of 7.13% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness and diagnosis, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Kenya Brugada Syndrome Market Analysis
The Kenya Brugada Syndrome Market was valued at $0.8 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $1.5 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and increasing healthcare expenditure. The prominent players of the Kenya Brugada Syndrome Market are Siemens Healthcare, Aventis Pasteur, Eli-Lilly, Regal Pharmaceuticals, GSK Nairobi, and Novartis Rhone Poulenic, among others.
Japan Blood Disorder Therapeutics Market
Japan Blood Disorder Therapeutics Market valued at $833 Mn in 2022, projected to reach $1,542 Mn by 2030 with a 8% CAGR. The key drivers of market growth include the higher prevalence of hemophilia A, improved awareness and diagnoses, growing adoption of advanced therapies, and government efforts to support the pharmaceutical industry. The Japan Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, Roche, Bayer, Novartis, KM Pharmaceuticals, Chugai Pharmaceuticals, Eisai, Kyowa Kirin, Daiichi Sankyo, etc, among various others.
South Africa Clinical Nutrition for Chronic Kidney Diseases Market Analysis
South Africa Clinical Nutrition for Chronic Kidney Diseases Market was valued at $ 10.20 Mn in 2023 and is predicted to grow at a CAGR of 7.26 % from 2023 to 2030, to $ 16.70 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
South Africa Brugada Syndrome Market Analysis
The South Africa Brugada Syndrome Market was valued at $7.8 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $14.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the South Africa Brugada Syndrome Market are Sun Pharma, Cipla, Bayer, Sanofi, Aspen Pharmacare, Astellas, and Medtronic, among others.
Saudi Arabia Blood Disorder Therapeutics Market
Saudi Arabia Blood Disorder Therapeutics Market valued at $228 Mn in 2022, projected to reach $454 Mn by 2030 with a 9% CAGR. Several factors are converging to cause market expansion, such as a young and expanding population, government initiatives supporting improved healthcare accessibility, advocacy groups raising awareness about advanced therapies, and digital healthcare integration. The Saudi Arabia Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, Takeda Pharmaceuticals, Novartis, Sanofi, Novo Nordisk, Bayer, Jamjoom Pharma, Tabuk Pharma, Tamer Pharma etc, among various others.
India Clinical Nutrition for Chronic Kidney Diseases Market Analysis
India Clinical Nutrition for Chronic Kidney Diseases Market was valued at $28.60 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $52.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
India Brugada Syndrome Market Analysis
The India Brugada Syndrome Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $44.7 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, advancements in genetic testing, and aging population. The prominent players of the India Brugada Syndrome Market are Intas, Sun Pharmaceuticals, Cipla, Divi's Lab, Dr. Reddy's Laboratories, and Zydus Lifesciences, among others.
Indonesia Blood Disorder Therapeutics Market
Indonesia Blood Disorder Therapeutics Market valued at $80 Mn in 2022, projected to reach $143 Mn by 2030 with a 7.5% CAGR. The market growth is fuelled due to certain factors such as the increasing incidence of blood disorders in Indonesia, driven by improved diagnostics and accessibility, heightened awareness, identification of genetic and environmental risk factors, and rising investments in healthcare. The Indonesia Blood Disorder Therapeutics Market encompasses various players across different segments, including Roche, Novartis, Pfizer, Bayer, BioMarin Pharmaceutical, Takeda, Kalbe Farma, Dexa Medica, Combiphar, Kimia Farma, etc, among various others.
Kenya Blood Disorder Therapeutics Market
Kenya Blood Disorder Therapeutics Market valued at $9 Mn in 2022, projected to reach $18 Mn by 2030 with a 8.6% CAGR. The market in Kenya is fuelled due to certain factors such as the increasing prevalence of blood disorders, higher expenditure on healthcare by the government, and the rise in technological innovations leading to safer and personalized medications. The Kenya Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Roche, Novartis, Sun Pharmaceuticals, Regal Pharmaceuticals, Nextgen Pharmaceuticals, Transwide Pharmaceuticals etc, among various others.
Mexico Blood Disorder Therapeutics Market
Mexico Blood Disorder Therapeutics Market valued at $201 Mn in 2022, projected to reach $365 Mn by 2030 with a 7.75% CAGR. Growth in the market is being driven by Mexico's increasing prevalence of age-related blood diseases, unmet medical needs of the population as well as improvements in treatments like gene and targeted therapy. The Mexico Market encompasses various players across different segments, including Takeda, Sanofi, CSL Ltd, Pfizer, Celgene Corporation, Alexion Pharmaceuticals, Amgen, Laboratorios Grin, PiSA Pharmaceutical Company, Genomma Lab Internacional, etc, among various others.
Saudi Arabia Clinical Nutrition Market Analysis
The Saudi Arabia Clinical Nutrition Market was valued at $521.4 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $828.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Almarai, Tabuk Pharmaceuticals, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among other.
Singapore Blood Disorder Therapeutics Market
Singapore Blood Disorder Therapeutics Market valued at $16 Mn in 2022, projected to reach $30 Mn by 2030 with a 8.1% CAGR. The market is expanding due to the rising prevalence of blood disorders brought on by aging populations and unhealthy lifestyle choices, therapeutic advancements supported by technology developments, and government programs that fund research and provide affordable therapies. The Singapore Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, BioLife Sciences, Agenus, Spark Therapeutics, Abeo Therapeutics, etc, among various others.
UAE Clinical Nutrition Market Analysis
The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.
South Africa Blood Disorder Therapeutics Market
South Africa Blood Disorder Therapeutics Market valued at $87 Mn in 2022, projected to reach $170 Mn by 2030 with a 8.37% CAGR. The key drivers include the implementation of initiatives like collaborative efforts between government agencies, NGOs, and pharmaceutical businesses, demographic factors influencing blood disorders prevalence, and the anticipation of introducing novel therapies, leading to increased research, development, and infrastructure investments in the field. The South Africa Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Aspen, Adcock Ingram, Eisai, BGM, Gilead Sciences, Sunrise Pharmaceuticals etc, among various others.
Brazil Clinical Nutrition Market Analysis
The Brazil Clinical Nutrition Market was valued at $766.8 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $1179 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Oceandrop, Vitafor, Prodiet Medical Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
Vietnam Blood Disorder Therapeutics Market
Vietnam Blood Disorder Therapeutics Market valued at $67 Mn in 2022, projected to reach $122 Mn by 2030 with a 7.73% CAGR. The key drivers of the market in Vietnam include the increasing prevalence of diseases such as aplastic anemia, hemophilia, and thalassemia due to advancements in diagnostics, lifestyle changes, and genetic susceptibility, supported by government initiatives prioritizing healthcare improvement in the country. The Vietnam Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, Sun Pharma, Teva, Ha Tay Pharma, Imexpharm, etc, among various others.
Mexico Clinical Nutrition Market Analysis
The Mexico Clinical Nutrition Market was valued at $460.1 Mn in 2023 and is projected to grow at a CAGR of 5.59% from 2023 to 2023, to $673.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such Amway, Herbalife, and Nestle.